Skip to content

News   /   Uncategorized

Can technology reverse the aging process?

Can technology reverse the aging process?
August 21, 2023

There is a hot new startup that has Silicon Valley buzzing right now. The newly formed company is called Altos Labs. And it just launched with an incredible $270 million Series A funding round. This values the company at nearly $1.4 billion. So Altos Labs was basically born a unicorn. That’s unheard of. And it’s all thanks to the company’s primary backers – Jeff Bezos and Yuri Milner. 

Amazon founder Jeff Bezos needs no introduction. As for Milner, he is a Russian tech entrepreneur who made a fortune on a Russian company called Mail.ru in the early 2000s. It was basically Russia’s version of Yahoo. Then Milner made another fortune as an early investor in Facebook about a decade later.  Needless to say, both Bezos and Milner are billionaires, and they are the key backers of Altos Labs’ Series A round. Naturally, that raises the question – why are these billionaires investing so heavily in this startup? And the answer is simple. 

Altos Labs is working on anti-aging technology. The goal is to extend human life. Bezos and Milner both have way more money than they could ever spend… and they want to use some of it to buy more time. That’s what this is about.  And what’s interesting here is that, with its billionaire backers, Altos Labs doesn’t have to worry much about profits. All that matters is results. For this reason, Altos Labs is hiring some of the most prominent scientists in the anti-aging space. The goal is to build an all-star team. The rumor is that Altos is paying some of these people salaries of more than $1 million per year to get them on board.  And so far the strategy is paying off…

The team at Altos Labs has made promising progress on reprogramming human cells in the laboratory. In fact, Altos has already demonstrated the ability to reverse the age of human cells by one-half. They did this by extracting cells from an 80-year old. They then applied their anti-aging tech to those cells in a lab and measured the cellular age. The reading suggested that the cells had become the equivalent of forty years old. Amazing.

That said, it is way too early in the process to inject the reprogrammed cells back into the human body, or for that matter to apply a similar therapy in vivo (in the body). Further animal testing will be needed to optimize the approach for safety.  So this is absolutely a company we need to track going forward. With a seemingly endless amount of capital available to fund moonshot ideas, there’s a good chance we might see a breakthrough here.  

There’s a lot of investment flowing into life-extension technology right now, and I believe we will see some incredible breakthroughs in the coming years. What’s more, this anti-aging technology will be informed by advances in genetic editing and our understanding of how proteins fold as well. That’s largely thanks to DeepMind’s AlphaFold2. When we combine these things with the application of artificial intelligence (AI), we are bound to see something miraculous happen.  

Simply put, this confluence of technologies will power anti-aging technology forward. The implications of that may be hard to quantify right now, but the investment potential is easy to envision. Let’s add Altos Labs to our early stage watchlist.

Share this article:

More in Uncategorized:

Best of US Investors

AI's Hidden Challenge: The Rising Demand for Data Center Cooling

As artificial intelligence (AI) continues to revolutionize industries across the globe, a less-discussed but critical challenge is emerging: the increasing...

Kerry Grinkmeyer in a suit standing in front of a stock chart with a bull on it

Kerry Grinkmeyer
June 20, 2024

Best of US Investors

Market Breadth Divergence - A Concerning Signal Ahead?

The stock market has been hitting new record highs lately, with the S&P 500 and Nasdaq making fresh all-time peaks....

Trent Grinkmeyer in front of stock market with bull background

Trent Grinkmeyer
June 19, 2024

Best of US Investors

The Looming Global Debt Crisis: A Ticking Time Bomb

The world is facing an unprecedented debt crisis, with global government debt reaching a staggering $315 trillion in the first...

Trent Grinkmeyer in front of stock market with bull background

Trent Grinkmeyer
June 11, 2024

Best of US Investors

A Safe Way to Invest in Cannabis with Innovative Industrial Properties

The U.S. cannabis industry remains highly fragmented and risky, but there is one outlier that provides investors with a relatively...

Trent Grinkmeyer in front of stock market with bull background

Trent Grinkmeyer
May 17, 2024

Best of US Investors

7 Stocks With Cosmic Potential - Finding the Next "Moonshot" Investments

May 16, 2024 By Kerry Grinkmeyer There are only two main ways to make big money in the stock market....

Can technology reverse the aging process?
May 16, 2024

Best of US Investors

Unveiling the Future with Emily Leproust and Twist Biosciences

In a world grappling with environmental challenges and the relentless pursuit of longevity, a visionary figure has emerged – Emily...

Kerry Grinkmeyer in a suit standing in front of a stock chart with a bull on it

Kerry Grinkmeyer
May 15, 2024

Register for the Best of US Investors Newsletter

Get daily financial news delivered to your inbox. Join today.

©2024 Best of US Investors. All rights reserved.

Site by KMA

Disclaimer

This Best of US Investors website is not and should not be considered investment advice. This Best of US Investors website is for informational purposes only. Nothing on this Best of US Investors website constitutes a recommendation to buy, sell or hold any security at any time. Always consult with a financial professional that is familiar with your specific situation before making any investment or trade.

Use of this Best of US Investors website is at your own risk. Best of US Investors makes no warranties about the accuracy, completeness or reliability of any content on this Best of US Investors website.

All the information on this Best of US Investors website is provided “AS IS”. Do not rely on any statements made on this Best of US Investors website.

In no event shall Best of US Investors be responsible or liable for any damage that occurs while using or reading any content on this Best of US Investors website.

Best of US Investors may have a position (long, short or neutral) in any security mentioned on this Best of US Investors website and therefore may realize significant gains in the event that the price of the security mentioned on this Best of US Investors website declines or appreciates.

Best of US Investors may buy and/or sell any security mentioned on this Twitter account at any time and for any reason. I may trade contrary or different to the information provided on this Best of US Investors website. You should assume that any email or post on this Best of US Investors website may cause the price of the security mentioned to appreciate or decline in a dramatic way.

Best of US Investors may continue to transact in any security mentioned on this Best of US Investors website an indefinite period of time after any email or post and such positions may be long, short or neutral at any time hereafter regardless of the initial view or positions stated on this Best of US Investors website.

In no event shall Best of US Investors be liable for any claims, losses, costs or damages of any kind including direct, indirect, punitive, exemplary, incidental, special or consequential damages, arising out of or in any way connected with any information presented on this Best of US Investors website. This limitation of liability applies regardless of any negligence or gross negligence of Best of US Investors or any company affiliated with Best of US Investors. You accept all risks in relying on the information presented on this Best of US Investors website.

If any statement in this legal disclaimer is held to be invalid or unenforceable, then the remaining provisions shall continue in full force and effect.

For more information, contact [email protected] .